(Q34445091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

review article

1 reference

title

Review of testing for human immunodeficiency virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Review of Testing for Human Immunodeficiency Virus (English)

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

15 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611822

15 October 2022

author name string

Bylund DJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Ziegner UH

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Hooper DG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1611822

15 October 2022

publication date

1 June 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:S0272271218305171?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

https://api.elsevier.com/content/article/PII:S0272271218305171?httpAccept=text/plain

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Clinics in laboratory medicine

15 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

305-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Incubation periods for paediatric AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HIV-2 infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

New questions about AIDS test accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Anti-IgM screening for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Reporting the results of human immunodeficiency virus testing

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human Immunodeficiency Virus Type 1 Infection in Homosexual Men Who Remain Seronegative for Prolonged Periods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HIV epidemiology: past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Feto-maternal transfusion after chorionic villus sampling: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Measurement of the False Positive Rate in a Screening Program for Human Immunodeficiency Virus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

False-positive Western blot tests for antibodies to HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Isolation of a new human retrovirus from West African patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Preliminary report: accurate assays for anti-HIV in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibody response to human immunodeficiency virus after primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection of human immunodeficiency virus-infected lymphoid cells at low frequency by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

False-positive Western blot reactions to human immunodeficiency virus in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Epidemiology of HIV infection and AIDS in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Early diagnosis of HIV infection in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Comparative study with in situ hybridization and immunocytochemistry in detection of HIV-1 in formalin-fixed paraffin-embedded cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Rapid test for distinguishing HIV-1 and HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Early markers of HIV-1 infection in plasma donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Are human immunodeficiency virus test reports clear to clinicians?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibody response in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Anti-HIV antibody testing: procedures and precautions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Testing for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Caveat: false positive results of HIV testing

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HIV-1 testing: product development strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serological characterization of HTLV-III infection in AIDS and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Prenatal diagnosis of fetal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antigen detection for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Molecular biology of the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Silent HIV infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Rapid screening tests for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Duration of human immunodeficiency virus infection before detection of antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Sensitivity and interobserver variability of the Recombigen-HIV-1 LA test.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Practical diagnostic testing for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Comparison of reverse transcriptase assay with the Retro-Tek viral capture assay for detection of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Characterization of the serologic profile of children with human immunodeficiency virus infection: correlation with clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Presence of HTLV-III antibodies in immune serum globulin preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Application of flow cytometry to the study of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Immunologic abnormalities in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Efficacy of the latest generation of antibody assays for (early) detection of HIV 1 and HIV 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human immunodeficiency viruses and the pathogenesis of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Zidovudine concentrations in human fetal tissue: implications for perinatal AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection of infection with human immunodeficiency virus (HIV) type 1 in infants by an anti-HIV immunoglobulin A assay using recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

The decreasing risk of transfusion-associated AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Screening for HIV: can we afford the false positive rate?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Use of cytoplasmic dot-blot hybridization to detect human immunodeficiency virus RNA sequences in cultures of peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Natural history of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Circulating human immunodeficiency virus (HIV) p24 antigen-positive lymphocytes: a flow cytometric measure of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HTLV-III/LAV infection in hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HIV viral sequences in seronegative people at risk detected by in situ hybridisation and polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

AIDS: an international perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Use of urine for HIV-1 antibody screening

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Elevated soluble interleukin-2 receptor levels in serum of human immunodeficiency virus infected populations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

The case for wider use of testing for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Use of the Polymerase Chain Reaction for Early Detection of the Proviral Sequences of Human Immunodeficiency Virus in Infants Born to Seropositive Mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Immunopathogenesis of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serodiagnosis of infection with the AIDS virus and other human retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Strategies for screening blood for human immunodeficiency virus antibody. Use of a decision support system

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

HTLV-III infection in brains of children and adults with AIDS encephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Predictive value of a screening test for antibodies to HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

False-positive enzyme-linked immunosorbent assay reactions for antibody to human immunodeficiency virus in a population of midwestern patients with congenital bleeding disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Serologic testing for human immunodeficiency virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Confirmation of HIV seropositivity: comparison of a novel radioimmunoprecipitation assay to immunoblotting and virus culture

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Studies of the sensitivity and reproducibility of commercial kits to detect antibodies to the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

The biochemistry of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Natural killer cell activity as a prognostic parameter in the progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Clinical performance of a polymerase chain reaction testing algorithm for diagnosis of HIV-1 infection in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

The polymerase chain reaction in the diagnosis of vertically transmitted HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Human T-lymphotropic retroviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-2712%2818%2930517-1

7 January 2021

Laboratory diagnosis of human immunodeficiency virus infection

27

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS

15 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

MOTHER-TO-CHILD TRANSMISSION OF HIV INFECTION

15 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Comparison of sensitivities and specificities of latex agglutination and an enzyme-linked immunosorbent assay for detection of antibodies to the human immunodeficiency virus in African sera

15 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.

15 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Human immunodeficiency virus type 1 antigen and culture assays

15 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Retrovirus infections and the acquired immunodeficiency syndrome

15 October 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

15 October 2022

128

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry

15 October 2022

139

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

Polymerase chain reaction: trenches to benches

15 October 2022

158

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30517-1

15 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1611822%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference